| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Accounts Receivable Collection |
|
Useful Advices - Accounts Receivable Collection
Accounts receivable factoring refers to a process in which you can sell your invoices to a finan According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product cing company for a rate, less than the face value of the invoice sold. The responsibility of co ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in lecting cash against the outstanding receivables lies with the financing company, who then makes lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. a profit by collecting the funds at the face value of the invoice. The advantage of this arrang here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ment is that a firm can receive instant cash, which was otherwise tied up in inventory, to furt d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro er expand the business. Again, the responsibility of collecting the cash against the invoices l ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ies with the financing company. To collect the cash, the financing company needs to keep the out easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi tanding receivables as current, and then work out a time line to collect the cash. Also, it is v nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ery important to keep a track or record of all communications that took place between the financ and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ng company and the customers. This can be done by keeping records of copies of letters, notes, d ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi te and time of phone calls and the name of person contacted. The company first sends a friendly ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a reminder letter to the customer to remind him that the date of the invoice is past due. In addi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ion to sending a formal reminder in the form of a letter, the company also contacts the customer cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin by phone. Apart from sending a reminder, the phone call is also intended to talk to the custome tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen personally and enquire about the reason for late payment. For example, the payment might have b t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel en delayed because of the problems with sales or merchandise and this may require sorting out. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust After the first letter and the phone call, the company waits for a few days for the customer's r y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products sponse and then once again sends the billing letter and makes another phone call as a reminder. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de If after this there is still no response, the company then contacts the customer with the collec elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ion agency letter. This is basically to give the customer one last opportunity to clear his dues tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Avoid e-mail Overload and Still Keep Everyone Informed Nina Winters Wins Sculpture Commission for New Native American Cultural Center Data Mining Models - Tom's Ten Data Tips
|